Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 1
2005 5
2006 4
2007 6
2008 1
2009 3
2010 2
2011 3
2012 2
2013 3
2014 3
2015 3
2016 3
2017 2
2018 2
2019 4
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.
Pomeroy EJ, Hunzeker JT, Kluesner MG, Lahr WS, Smeester BA, Crosby MR, Lonetree CL, Yamamoto K, Bendzick L, Miller JS, Geller MA, Walcheck B, Felices M, Webber BR, Starr TK, Moriarity BS. Pomeroy EJ, et al. Among authors: walcheck b. Mol Ther. 2020 Jan 8;28(1):52-63. doi: 10.1016/j.ymthe.2019.10.009. Epub 2019 Oct 15. Mol Ther. 2020. PMID: 31704085 Free PMC article.
iNK-CD64/16A cells: a promising approach for ADCC?
Walcheck B, Wu J. Walcheck B, et al. Expert Opin Biol Ther. 2019 Dec;19(12):1229-1232. doi: 10.1080/14712598.2019.1667974. Epub 2019 Sep 19. Expert Opin Biol Ther. 2019. PMID: 31510805 Free PMC article.
ADAM-17-independent shedding of L-selectin.
Walcheck B, Alexander SR, St Hill CA, Matala E. Walcheck B, et al. J Leukoc Biol. 2003 Sep;74(3):389-94. doi: 10.1189/jlb.0403141. J Leukoc Biol. 2003. PMID: 12949242
52 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page